China STEMI-PCI Program

NCT01716884 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2012-10-30

No results posted yet for this study

Summary

1. Registration
2. Performing in three stages
3. Major aim: Much more and standard reperfusion therapy in STEMI patients

Conditions

  • ST Segment Elevation Myocardial Infarction

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY
  • Sanofi

    collaborator INDUSTRY
  • Peking University First Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2015-12-31
Completion
2016-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01716884 on ClinicalTrials.gov